Year founded
-
Country of origin
United States
HQ country
United States
Total deal value
Average deal value
Company industry
- Healthcare & Pharmaceuticals
M&A expertise
- -
Industry expertise
- Healthcare & Pharmaceuticals
Omrix Biopharmaceuticals, Inc. founded in 1998, develops, manufactures, and markets biological products for the bio surgical and immunotherapy markets. It offers various bio surgical products and product candidates, which are a fibrin sealant used as an adjunct to hemostasis in surgical procedures, and marketed as Evicel in United States and as Quixil outside of U.S.; and Evithrom, a thrombin product primarily for use in neurosurgery.
Latest deals
Johnson & Johnson acquires Omrix Biopharmaceuticals, Inc. from Omrix Biopharmaceuticals Shareholders
24-11-2008
€ 250 - 500 million